Advances in Cancer Research

Other | July 1, 2011

byVande Woude, George F., George F. Vande Woude

not yet rated|write a review
TheAdvances in Cancer Researchseries provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone: current status.

Pricing and Purchase Info

$186.99 online
$242.78 list price (save 22%)
In stock online
Ships free on orders over $25

From the Publisher

TheAdvances in Cancer Researchseries provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differen...

Format:OtherDimensions:376 pages, 1 × 1 × 1 inPublished:July 1, 2011Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0080464483

ISBN - 13:9780080464480

Customer Reviews of Advances in Cancer Research

Reviews

Extra Content

Table of Contents

NY-ESO-1: Review of an Immunogenic Tumor Antigen.
Order, Disorder, Death: Lessons from a Superorganism.
Control of Differentiation in Progression of Epithelial Tumors.
Cancer Vaccines: Preclinical Studies and Novel Strategies.
Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future.
Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T-Cell Based Cancer Vaccines.
NK Cell Receptors as Tools in Cancer Immunotherapy.
Innate Immune Recognition and Suppression of Tumors.
Inhibitors of the HSP90 Molecular Chaperone: Current Status.